Features Screener Stocks Charts
Sign In Sign Up

Jubilant Pharmova Income Statement

NSE:JUBLPHARMA | PHARMACEUTICALS

Showing 2 of 10 years of data. Sign up free for 3 years, or upgrade for full access.

View Plans

2-year JUBLPHARMA income statement snapshot

Hover the chart icon for YoY change.

FY 2024 - FY 2025
Item Chart 2024 2025
Revenue 67.72B 72.91B
Cost of Revenue -21.41B -23.17B
Gross Profit 46.31B 49.74B
Sales, General & Admin -36.61B -37.44B
Operating Income 5.88B 8.62B
Profit Before Tax 1.71B 9.81B
Net Income 727.00M 8.36B
Diluted Shares 158.36M 158.42M
Diluted EPS 4.86 52.85

Values are shown in millions (M) and billions (B). All amounts are in Indian Rupees (₹). EPS is earnings per share.

Data from audited consolidated filings. For educational purposes only — not investment advice. Last update: Mar-2025